{
  "drug_name": "Flecainide",
  "url": "https://wikem.org/wiki/Flecainide",
  "scraped_at": "2026-01-10T07:53:30.595452",
  "sections": {
    "Administration": {
      "text": "Type: Antiarrhythmic\nDosage Forms:\nRoutes of Administration: PO\nCommon Trade Names:",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adult_Dosing": {
      "text": "Atrial fibrillation, cardioversion (\"pill-in-a-pocket\")\n200-300mg PO once\nParoxysmal atrial tachycardia (prophylaxis)\n50-150mg PO BID",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "25-100 mg/m(2) PO 2-3 times per day, MAX dose 200 mg/m(2)/day",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: C\nLactation risk\n: Infant risk minimal\nRenal dosing: adjustment may be required\nHepatic dosing: adjustment may be required",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        },
        {
          "text": "Lactation risk",
          "url": "https://wikem.org/wiki/Lactation_risk_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nCardiogenic shock\nRight bundle branch block (without pacemaker)\n2nd or 3rd degree AV block (without pacemaker)",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Heart block, sinus node dysfunction\nTorsades de pointes, ventricular tachycardia, ventricular fibrillation\nCardiac shock, cardiac arrest\nNew onset or worsening heart failure",
          "tables": []
        },
        "Common": {
          "text": "Dizziness, fatigue, blurred vision\nNausea\nDyspnea",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "Heart block, sinus node dysfunction\nTorsades de pointes, ventricular tachycardia, ventricular fibrillation\nCardiac shock, cardiac arrest\nNew onset or worsening heart failure",
      "subsections": {
        "Common": {
          "text": "Dizziness, fatigue, blurred vision\nNausea\nDyspnea",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "Dizziness, fatigue, blurred vision\nNausea\nDyspnea",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 12-27h\nMetabolism: Hepatic, CYP2D6\nExcretion:",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Class I C antiarrhythmic, Na+ channel blocker",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "antiarrhythmics",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "antiarrhythmics",
          "url": "https://wikem.org/wiki/Antiarrhythmics"
        }
      ]
    }
  }
}